Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Thursday 26 March, 2020

Morgan Stanley&CoLLC

Rule 38.5 - Replacement of ABBVIE INC

RNS Number : 7489H
Morgan Stanley & Co. LLC
26 March 2020
 

AMENDMENT  Section 2(a)

 

  FORM 38.5

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)

 

DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS

 

1.  KEY INFORMATION

 Name of exempt market-maker

  Morgan Stanley & Co. LLC

 Company dealt in

  ABBVIE INC.

 Class of relevant security to which the dealings being disclosed relate (Note 1)

  US$0.01 COMMON STOCK

 Date of dealing

  16 MARCH 2020

 

 

2.  DEALINGS  (Note 2)

 

(a)  Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

   2,161,095

 82.1800 USD

 73.5900 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

   2,161,192

 82.1800 USD

 73.5900 USD

 

 

(b)  Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

  (Note 4)

 Number of relevant securities

  (Note 5)

 Price per unit

 N/A

 N/A

 N/A

 N/A

 

 

(c)  Options transactions in respect of existing relevant securities

 

i)  Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 PUT

 PURCHASE

 400

 60.0000

A

 21/08/2020

 4.0900 USD

 PUT

 PURCHASE

 100

 60.0000

A

 21/08/2020

 4.0900 USD

 CALL

 PURCHASE

 100

 88.0000

A

 20/03/2020

 0.6200 USD

 CALL

 PURCHASE

 100

 86.0000

A

 20/03/2020

 1.1000 USD

 CALL

 PURCHASE

 100

 95.0000

A

 15/05/2020

 1.2100 USD

 PUT

 PURCHASE

 100

 74.0000

A

 20/03/2020

 2.1000 USD

 PUT

 PURCHASE

 200

 74.0000

A

 20/03/2020

 2.1000 USD

 PUT

 PURCHASE

 100

 75.0000

A

 20/03/2020

 2.2600 USD

 CALL

 PURCHASE

 100

 85.0000

A

 15/05/2020

 2.4600 USD

 PUT

 PURCHASE

 1,000

 77.5000

A

 20/03/2020

 2.7500 USD

 CALL

 PURCHASE

 2,900

 85.0000

A

 19/06/2020

 3.4200 USD

 CALL

 PURCHASE

 500

 82.5000

A

 15/05/2020

 4.7900 USD

 CALL

 PURCHASE

 500

 82.5000

A

 15/05/2020

 4.7900 USD

 CALL

 PURCHASE

 9,500

 77.5000

A

 15/05/2020

 5.0200 USD

 PUT

 PURCHASE

 100

 75.0000

A

 17/04/2020

 5.1600 USD

 CALL

 PURCHASE

 2,600

 77.5000

A

 15/05/2020

 5.3600 USD

 CALL

 PURCHASE

 100

 77.5000

A

 19/06/2020

 8.0100 USD

 CALL

 PURCHASE

 100

 77.5000

A

 19/06/2020

 8.0100 USD

 CALL

 SALE

 400

 100.0000

A

 20/03/2020

 0.0100 USD

 CALL

 SALE

 200

 90.0000

A

 20/03/2020

 0.0500 USD

 CALL

 SALE

 200

 90.0000

A

 20/03/2020

 0.0500 USD

 CALL

 SALE

 100

 95.0000

A

 20/03/2020

 0.1000 USD

 CALL

 SALE

 100

 95.0000

A

 20/03/2020

 0.1000 USD

 CALL

 SALE

 100

 90.0000

A

 20/03/2020

 0.2900 USD

 PUT

 SALE

 200

 35.0000

A

 19/06/2020

 0.3800 USD

 CALL

 SALE

 100

 87.0000

A

 20/03/2020

 0.4300 USD

 CALL

 SALE

 200

 87.0000

A

 20/03/2020

 0.4300 USD

 CALL

 SALE

 100

 97.5000

A

 17/04/2020

 0.4400 USD

 PUT

 SALE

 200

 35.0000

A

 19/06/2020

 0.4600 USD

 CALL

 SALE

 100

 88.5000

A

 20/03/2020

 0.4700 USD

 CALL

 SALE

 500

 86.0000

A

 20/03/2020

 0.5300 USD

 PUT

 SALE

 100

 35.0000

A

 19/06/2020

 0.5300 USD

 CALL

 SALE

 500

 100.0000

A

 15/05/2020

 0.5700 USD

 CALL

 SALE

 2,900

 95.0000

A

 15/05/2020

 1.0200 USD

 CALL

 SALE

 100

 90.0000

A

 17/04/2020

 1.3000 USD

 CALL

 SALE

 100

 110.0000

A

 15/01/2021

 1.3300 USD

 CALL

 SALE

 100

 110.0000

A

 15/01/2021

 1.3300 USD

 CALL

 SALE

 100

 100.0000

A

 19/06/2020

 1.5500 USD

 CALL

 SALE

 5,000

 85.0000

A

 15/05/2020

 2.5300 USD

 PUT

 SALE

 500

 70.0000

A

 17/04/2020

 3.3500 USD

 CALL

 SALE

 100

 100.0000

A

 21/01/2022

 5.1000 USD

 CALL

 SALE

 500

 80.0000

A

 15/05/2020

 5.6400 USD

 CALL

 SALE

 100

 76.0000

A

 09/04/2020

 6.3500 USD

 PUT

 SALE

 200

 80.0000

A

 09/04/2020

 6.4000 USD

 PUT

 SALE

 100

 80.0000

A

 09/04/2020

 6.4000 USD

 PUT

 SALE

 800

 72.5000

A

 18/09/2020

 8.8000 USD

 PUT

 SALE

 100

 75.0000

A

 21/08/2020

 9.1400 USD

 PUT

 SALE

 400

 75.0000

A

 21/08/2020

 9.1400 USD

 CALL

 SALE

 100

 80.0000

A

 15/01/2021

 9.2500 USD

 PUT

 SALE

 100

 85.0000

A

 15/05/2020

 10.2200 USD

 PUT

 SALE

 200

 85.0000

A

 15/05/2020

 10.2200 USD

 CALL

 SALE

 100

 75.0000

A

 15/01/2021

 12.8200 USD

 PUT

 SALE

 100

 90.0000

A

 17/04/2020

 12.9900 USD

 PUT

 SALE

 100

 80.0000

A

 21/01/2022

 21.7500 USD

 PUT

 SALE

 100

 80.0000

A

 21/01/2022

 21.7500 USD

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 PUT

 500

 98.0000 USD

 PUT

 12,700

 95.0000 USD

 PUT

 1,800

 100.0000 USD

 PUT

 1,300

 99.0000 USD

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

 26 MARCH 2020

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ABBVIE INC.

Nature of connection (Note 6)

Advisory

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEDZGZFFVKGGZM

a d v e r t i s e m e n t